We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Cerilliant Introduces Certified Spiking Solutions® of Bath Salt Metabolites
Product News

Cerilliant Introduces Certified Spiking Solutions® of Bath Salt Metabolites

Cerilliant Introduces Certified Spiking Solutions® of Bath Salt Metabolites
Product News

Cerilliant Introduces Certified Spiking Solutions® of Bath Salt Metabolites


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Cerilliant Introduces Certified Spiking Solutions® of Bath Salt Metabolites"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Cerilliant has introduced seven new Certified Spiking Solutions® of bath salt metabolites. The new products are 1.0 mg/mL (as free base) in methanol for the primary urinary metabolites of bath salt cathinones, mephedrone, buphedrone, pentedrone, flephedrone, N-ethylcathinone, and 4-methylethcathinone.

For GC/MS and LC/MS methods that quantify concentrations of synthetic cathinone metabolites, Cerilliant also offers the corresponding deuterium-labeled internal standard to compliment this new line of certified reference solutions.

Metabolism of synthetic cathinones presents significant challenges to the analytical laboratory. Routine screening of parent synthetic cathinones by GC/MS or LC/MS is not always sufficient to identify a positive result, because many of the parent drugs are extensively converted to reduced or dealkylated metabolites.

Some laboratories have reported a substantial number of specimens that contain reduced metabolites of synthetic cathinones, but no trace of the parent drugs.

In these cases, screening user samples for the presence of the metabolites would be critical to confirm a positive result.

“The synthetic cathinone metabolites product line provides our customers additional certified solution standards for their bath salt testing methods, especially for cases where the user samples may only contain the metabolites and no parent drug,” states Derrell Johnson, Cerilliant’s New Product Development Manager.

Cerilliant offers a wide selection of certified Snap-N-Spike® solutions for use in clinical toxicology applications, medication monitoring, forensic analysis, employee drug screening, and
urine drug testing including parent drug, metabolite, and internal standard Certified Spiking Solutions® of benzodiazepines, opiates and synthetic analgesics, anticonvulsants, cannabinoids, antidepressants, barbiturates, and alcohol/ethanol in addition to synthetic cathinones and cannabinoids including Spice as well as other new designer drugs.

Cerilliant Snap-N-Spike® solutions are prepared and certified to the highest industry standards including ISO Guide 34, ISO 17025 and ISO 13485.

For standards of controlled substances, our DEA exemptions allow laboratories to order these standards without DEA paperwork.

Advertisement